Show simple item record

dc.contributor.authorEdbrooke, Lara
dc.contributor.authorDenehy, Linda
dc.contributor.authorPatrick, Cameron
dc.contributor.authorTuffaha, Haitham
dc.date.accessioned2021-09-27T04:05:15Z
dc.date.available2021-09-27T04:05:15Z
dc.date.issued2021
dc.identifier.issn0961-5423
dc.identifier.doi10.1111/ecc.13501
dc.identifier.urihttp://hdl.handle.net/10072/408412
dc.description.abstractObjective: Few economic evaluations of lung cancer rehabilitation exist. The aim of this study was to assess the cost-effectiveness of providing home-based rehabilitation for inoperable lung cancer. Methods: A cost-utility analysis alongside a randomised controlled trial (RCT) of rehabilitation compared with usual care. The primary outcome was quality-adjusted life years (QALYs) gained. The incremental cost-effectiveness ratio [ICER (95% CI)] and the net monetary benefit are reported. Value of information (VOI) analysis assessed the need/value of more research. Results: Seventy participants (34 intervention and 36 usual care), average (SD) age 63.0 (12.0) years, 32 (45.7%) stage IV. The average intervention cost was AU$3421 (AU$5352 usual care), and effect (QALY) was 0.30 (0.31 usual care). The ICER was AU$228,197 (−1,173,194 to 1,101,450) per QALY gained. The net monetary benefit was AU$1508, favouring the intervention. The probability that the intervention was more cost-effective than usual care, at a willingness to pay threshold of AU$50,000, was 75%. VOI analysis showed that additional research to resolve decision uncertainty is potentially worthwhile. Conclusion: A high degree of uncertainty exists regarding the cost-effectiveness of lung cancer rehabilitation. Further RCTs, powered for economic evaluations and utilising rehabilitation sensitive outcomes, are required to support translation of evidence into clinical practice.
dc.description.peerreviewedYes
dc.languageEnglish
dc.publisherWiley
dc.relation.ispartofjournalEuropean Journal of Cancer Care
dc.subject.fieldofresearchOncology and carcinogenesis
dc.subject.fieldofresearchNursing
dc.subject.fieldofresearchPublic health
dc.subject.fieldofresearchHealth economics
dc.subject.fieldofresearchcode3211
dc.subject.fieldofresearchcode4205
dc.subject.fieldofresearchcode4206
dc.subject.fieldofresearchcode380108
dc.subject.keywordsScience & Technology
dc.subject.keywordsLife Sciences & Biomedicine
dc.subject.keywordsHealth Care Sciences & Services
dc.titleCost-effectiveness analysis of home-based rehabilitation compared to usual care for people with inoperable lung cancer
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationEdbrooke, L; Denehy, L; Patrick, C; Tuffaha, H, Cost-effectiveness analysis of home-based rehabilitation compared to usual care for people with inoperable lung cancer, European Journal of Cancer Care, 2021
dcterms.dateAccepted2021-07-23
dc.date.updated2021-09-17T00:47:24Z
gro.description.notepublicThis publication has been entered in Griffith Research Online as an advanced online version.
gro.hasfulltextNo Full Text
gro.griffith.authorTuffaha, Haitham W.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record